KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/08/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization150,786 mln
Float17.25 mln
EPS
673
Exceptional
P / E
7.74
Undervalued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.37
Borderline
Relative Strength
49
/ 100
In line with market
Debt / Equity
0.31
Low leverage
Business Description
Founded in 1897 and based in Seoul, Dongwha Pharm is one of South Korea's longest-standing pharmaceutical companies. It produces a wide range of prescription and over-the-counter medicines covering areas such as heart health, digestion, pain relief, skin care, and the nervous system. Beyond medicines, the company also sells health foods, cosmetics, and personal care products, and distributes its offerings to international markets.
